Skip to content

The effect of aromatherapy with lavender essential oil on sexual function in menopausal women

Examining the effect of aromatherapy with lavender essential oil on sexual function in postmenopausal women: A randomized controlled trial study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20090525001946N13
Enrollment
148
Registered
2025-09-15
Start date
2025-11-22
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopause is not a disease.. Menopausal and female climacteric states

Interventions

Intervention 1: Intervention group: 2 drops of 2% lavender essential oil will be inhaled for three consecutive nights a week for one month. The ingredients of lavender essential oil are (linalool acet

Sponsors

Rasht University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to No maximum

Inclusion criteria

Inclusion criteria: The individual's willingness to participate in the study absence of menstruation in the last 12 months age over 45 years having normal blood pressure

Exclusion criteria

Exclusion criteria: Having malignancies Menopause with pathological causes Women with previously diagnosed psychiatric disorders women treated with medication for vasomotor symptoms, depression, use of anti-anxiety drugs, narcotics, estrogen and progesterone in the last six years Having a history of allergic rhinitis and other respiratory problems and sinusitis Family history of breast or ovarian cancer Women with severe depression and clinical visit by a psychiatrist Women requiring antidepressants due to lack of improvement in symptoms Women with thoughts of harming themselves and those around them Widowed, single and divorced women Women with postmenopausal bleeding Symptoms such as shortness of breath or allergic symptoms

Design outcomes

Primary

MeasureTime frame
Women's sexual performance score and its dimensions. Timepoint: Before and 1 month after the intervention, both the control and intervention groups will be determined. Method of measurement: The 16-question Female Sexual Function Index (FSFI-16) questionnaire will be completed by participants.

Secondary

MeasureTime frame
-. Timepoint: -. Method of measurement: -.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mandana Mansour-Ghanaie

Rasht University of Medical Sciences

m_m_ghanaie@yahoo.com+98 13 3336 9224

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026